Published in AIDS Weekly and Law, September 7th, 2006
"There is a remarkable heterogeneity in the functional profile (quality) of T cell responses. Importantly, the magnitude and/or quality of a response required for protection may be different depending on the infection. We assessed the capacity of different Toll like receptor (TLR)-binding compounds to influence T helper cell (Th) 1 and CD8+ T cell responses when used as adjuvants in nonhuman primates (NHP) with HIV Gag as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.